Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-098886
Filing Date
2025-10-15
Accepted
2025-10-14 17:45:53
Documents
12
Period of Report
2025-10-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K ea026130201-8ka_alphacog.htm   iXBRL 8-K/A 31450
  Complete submission text file 0001213900-25-098886.txt   202425

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE acog-20251010.xsd EX-101.SCH 3041
3 XBRL LABEL FILE acog-20251010_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE acog-20251010_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT ea026130201-8ka_alphacog_htm.xml XML 3902
Mailing Address 1452 HUGHES RD., STE. 200 GRAPEVINE TX 76051
Business Address 1200-750 W PENDER ST VANCOUVER BRITISH COLUMBIA British Columbia, Canada V6C 2T8 (858) 344-4375
Alpha Cognition Inc. (Filer) CIK: 0001655923 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-42403 | Film No.: 251392858
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)